Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sheng Chih Fan"'
Autor:
Po-Han Lin, Ming-Yang Wang, Chiao Lo, Li-Wei Tsai, Tzu-Chun Yen, Thomas Yoyan Huang, Wei-Chih Huang, Karen Yang, Chih-Kai Chen, Sheng-Chih Fan, Sung-Hsin Kuo, Chiun-Sheng Huang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPatients with stage II to III breast cancer have a high recurrence rate. The early detection of recurrent breast cancer remains a major unmet need. Circulating tumor DNA (ctDNA) has been proven to be a marker of disease progression in metas
Externí odkaz:
https://doaj.org/article/5c086e33a22b4ccca39c569b8be44274
Autor:
Tzu-Chun Yen, Chiao Lo, Sheng-Chih Fan, Li-Wei Tsai, Chih-Kai Chen, Chiun-Sheng Huang, Ming Chen, Thomas Yoyan Huang, Po-Han Lin, Sung-Hsin Kuo
Publikováno v:
Cancer Science
BRCAness is considered a predictive biomarker to platinum and poly(ADP‐ribose) polymerase (PARP) inhibitors. However, recent trials showed that its predictive value was limited in triple‐negative breast cancer (TNBC) treated with platinum. Moreov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67ab5dc6801beb28ef7d796ebfe4a659
https://pubmed.ncbi.nlm.nih.gov/31958182
https://pubmed.ncbi.nlm.nih.gov/31958182
Autor:
Ming Hsin Yeh, Sheng Chih Fan, Huei Ying Li, Po-Han Lin, Yu Hua Hsu, Chunyu Liu, Ming-Yang Wang, Ching-Hung Lin, King-Jen Chang, Yu Hsuan Yang, Pei-Lung Chen, Fiona Tsui-Fen Cheng, Long Yuan Li, Yen-Shen Lu, Sung-Liang Yu, Wen-Hung Kuo, Yen-Hsuan Ni, Sung-Hsin Kuo, Ai Chu Huang, Chiun-Sheng Huang
Publikováno v:
Oncotarget
Since BRCA mutations are only responsible for 10-20% of cases of breast cancer in patients with early-onset or a family history and since next-generation sequencing technology allows the simultaneous sequencing of a large number of target genes, test
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85bda402474178f150c5600b08f82a80
https://doi.org/10.18632/oncotarget.7027
https://doi.org/10.18632/oncotarget.7027
Autor:
Su-Peng Yeh, Chen Yuan Lin, Yu Min Liao, Huei Ying Li, Yu Hsuan Yang, Po-Han Lin, Yu Hua Hsu, Tzu Hang Yuan, Ming Chen, Li Yuan Bai, Chang Fang Chiu, Tzu Ting Chen, Che Hung Lin, Ching Yun Hsieh, Sheng Chih Fan, Ching Chan Lin, Yen-Hsuan Ni, Ming-Yu Lien, Long Yuan Li
Publikováno v:
Cancer Medicine
Conventional cytogenetics can categorize patients with acute myeloid leukemia (AML) into favorable, intermediate, and unfavorable‐risk groups; however, patients with intermediate‐risk cytogenetics represent the major population with variable outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd28bc7b1a67d9bac9ce99fcaae1b72f
https://pubmed.ncbi.nlm.nih.gov/28070990
https://pubmed.ncbi.nlm.nih.gov/28070990